Presentation on theme: "STAGING MCR Staff Show Me Healthy Women March 27, 2008 Supported by a Cooperative Agreement between DHSS and the Centers for Disease Control and Prevention."— Presentation transcript:
STAGING MCR Staff Show Me Healthy Women March 27, 2008 Supported by a Cooperative Agreement between DHSS and the Centers for Disease Control and Prevention (CDC) and a Surveillance Contract between DHSS and MU
Staging Grouping of cancer cases according to similar degrees of spread or extent of disease. Extent of disease is a detailed description of how far the tumor has spread from organ or site of origin (the primary site).
Staging PURPOSES Determine appropriate treatment Predict prognosis Evaluate results of treatment Facilitate exchange of information Contribute to research of human cancer
Staging Elements Elements to be considered in any staging system are the primary tumor site, tumor size, multiplicity (number of tumors), depth of invasion and extension to regional or distant tissues, involvement of regional lymph nodes, and distant metastases.
Types of Staging Systems Summary Staging American Joint Committee on Cancer (AJCC) Staging System Collaborative Staging Others FIGO (GYN) Dukes (colorectal) Ann Arbor ( Lymphoma)
FIGO Acronym for the French term that means International Federation for Gynecology and Obstetrics. The American Joint Committee on Cancer has developed the tumor (T) component of the TNM staging system to correspond to FIGO staging.
How to? Where did the cancer start? Where did the cancer go? How did the cancer get there? What is the stage?
Summary Staging 0 – in situ 1 – localized 2 – regional by direct extension only 3 – regional lymph nodes involved only 4 – regional by both direct extension and lymph node involvement 5 – regional, NOS (not otherwise specified) 7 - distant site(s)/node(s) involved 9 – unknown (unstaged, unknown or unspecified)
Collaborative Stage Collaborative Staging (CS) data items CS Extension CS Lymph Nodes CS Mets at Dx
Steps for Staging 1) Determine primary site & histology 3) Is histology included? 4) Review list of regional LNs 5) Review rules of classification 6) Find staging information in chart 7) Determine T, N, M and group stage
Missouri Cancer Registry Help Line: 800-392-2829 Help interpreting path report for staging http://mcr.umh.edu For further information, please contact: Sue Vest, Project Manager, email@example.com firstname.lastname@example.org Nancy Cole, Assistant Project Manager email@example.com